{
    "NCT02008357": {
        "relevance_explanation": "The patient's condition of progressive memory loss and cognitive deficits aligns with the target condition of the clinical trial, which is cognition disorders. However, the patient's specific test scores and brain amyloid pathology, which are required for inclusion, are not mentioned in the patient note. Therefore, the patient is somewhat relevant to the trial.",
        "relevance_score_R": 70.0,
        "eligibility_explanation": "The patient is not excluded by any of the mentioned exclusion criteria, as the patient note does not mention any of the conditions or treatments that would lead to exclusion. However, due to the lack of specific test scores and brain amyloid pathology information, it is not clear if the patient meets the inclusion criteria. Therefore, the patient's eligibility is uncertain.",
        "eligibility_score_E": 0.0
    },
    "NCT01900665": {
        "relevance_explanation": "The patient's symptoms of progressive memory loss and cognitive deficits are indicative of Alzheimer's Disease, which is the target condition of the clinical trial. However, the patient's specific diagnosis and the severity of his condition are not clearly stated in the patient note, and there is no direct evidence that the patient meets the specific criteria for probable AD as required by the trial's inclusion criteria.",
        "relevance_score_R": 70.0,
        "eligibility_explanation": "There is insufficient information in the patient note to determine whether the patient meets all of the trial's inclusion criteria or whether he is excluded by any of the trial's exclusion criteria. For example, there is no information about the patient's MMSE score, Geriatric Depression Scale score, or the results of any recent neuroimaging studies. Similarly, there is no information about the patient's caregiver, his history of other illnesses, or his use of medications that could affect his eligibility for the trial.",
        "eligibility_score_E": 0.0
    }
}